secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001193125-23-030375
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical to acquire NuVasive in all-stock merger; each NuVasive share gets 0.75 GMED share
--------------------------------------------------------------------------------

- Each NuVasive share converted into 0.75 Globus Medical Class A common shares; no cash consideration except fractional shares.
- Expected close by Oct 8, 2023, extendable to Feb 8, 2024; subject to HSR, shareholder approvals, and other conditions.
- Termination fees: NuVasive pays $120M (reduced to $75M in Specified Period); Globus pays $120M in certain scenarios.
- Globus board expanded to 11 members; 3 NuVasive directors to be appointed post-close.
- David & Sonali Paul (70% voting power) agree to vote Globus Class B shares in favor of issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/0001193125-23-030375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523030375/d447800d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-030375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer